Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President, Chief Research & Development Officer

Reata Pharmaceuticals, Inc. , a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced the appointment of Rajiv... | June 13, 2023

Related Keywords

New York ,United States ,Rajiv Patni ,Linkedin ,Research Development Officer ,Twitter ,Drug Administration ,Nasdaq ,Mount Sinai School Of Medicine ,Albert Einstein College Of Medicine ,Adamas Pharmaceuticals ,Pfizer ,European Medicines Agency ,Portola Pharmaceuticals ,Reata Pharmaceuticals Inc ,Reata Pharmaceuticals ,Executive Vice President ,Chief Research ,Warren Huff ,Chief Executive Officer ,Chief Executive ,Chief Medical Officer ,Global Blood Therapeutics ,Mount Sinai School ,New York City ,Albert Einstein College ,